These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 29128799)
1. FTY720 inhibits the Nrf2/ARE pathway in human glioblastoma cell lines and sensitizes glioblastoma cells to temozolomide. Zhang L; Wang H Pharmacol Rep; 2017 Dec; 69(6):1186-1193. PubMed ID: 29128799 [TBL] [Abstract][Full Text] [Related]
2. Temozolomide and irradiation combined treatment-induced Nrf2 activation increases chemoradiation sensitivity in human glioblastoma cells. Cong ZX; Wang HD; Zhou Y; Wang JW; Pan H; Zhang DD; Zhang L; Zhu L J Neurooncol; 2014 Jan; 116(1):41-8. PubMed ID: 24078215 [TBL] [Abstract][Full Text] [Related]
3. Knockdown of Nrf2 enhances autophagy induced by temozolomide in U251 human glioma cell line. Zhou Y; Wang HD; Zhu L; Cong ZX; Li N; Ji XJ; Pan H; Wang JW; Li WC Oncol Rep; 2013 Jan; 29(1):394-400. PubMed ID: 23128449 [TBL] [Abstract][Full Text] [Related]
4. MAPK8 mediates resistance to temozolomide and apoptosis of glioblastoma cells through MAPK signaling pathway. Xu P; Zhang G; Hou S; Sha LG Biomed Pharmacother; 2018 Oct; 106():1419-1427. PubMed ID: 30119215 [TBL] [Abstract][Full Text] [Related]
5. APE1/REF-1 down-regulation enhances the cytotoxic effects of temozolomide in a resistant glioblastoma cell line. Montaldi AP; Godoy PR; Sakamoto-Hojo ET Mutat Res Genet Toxicol Environ Mutagen; 2015 Nov; 793():19-29. PubMed ID: 26520369 [TBL] [Abstract][Full Text] [Related]
6. Long Non-Coding RNA MALAT1 Decreases the Sensitivity of Resistant Glioblastoma Cell Lines to Temozolomide. Li H; Yuan X; Yan D; Li D; Guan F; Dong Y; Wang H; Liu X; Yang B Cell Physiol Biochem; 2017; 42(3):1192-1201. PubMed ID: 28668966 [TBL] [Abstract][Full Text] [Related]
7. Sphingosine‑1‑phosphate analogue FTY720 exhibits a potent anti‑proliferative effect on glioblastoma cells. Kolodziej MA; Al Barim B; Nagl J; Weigand MA; Uhl E; Uhle F; Di Fazio P; Schwarm FP; Stein M Int J Oncol; 2020 Oct; 57(4):1039-1046. PubMed ID: 32945397 [TBL] [Abstract][Full Text] [Related]
8. Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine-γ-lyase function. Chen L; Li X; Liu L; Yu B; Xue Y; Liu Y Oncol Rep; 2015 Mar; 33(3):1465-74. PubMed ID: 25585997 [TBL] [Abstract][Full Text] [Related]
9. IDH1 R132H mutation regulates glioma chemosensitivity through Nrf2 pathway. Li K; Ouyang L; He M; Luo M; Cai W; Tu Y; Pi R; Liu A Oncotarget; 2017 Apr; 8(17):28865-28879. PubMed ID: 28427200 [TBL] [Abstract][Full Text] [Related]
10. Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner. Wagner L; Marschall V; Karl S; Cristofanon S; Zobel K; Deshayes K; Vucic D; Debatin KM; Fulda S Oncogene; 2013 Feb; 32(8):988-97. PubMed ID: 22469979 [TBL] [Abstract][Full Text] [Related]
11. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors. Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243 [TBL] [Abstract][Full Text] [Related]
12. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity. Shi L; Chen J; Yang J; Pan T; Zhang S; Wang Z Brain Res; 2010 Sep; 1352():255-64. PubMed ID: 20633539 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-21 inhibitor sensitizes human glioblastoma U251 stem cells to chemotherapeutic drug temozolomide. Zhang S; Wan Y; Pan T; Gu X; Qian C; Sun G; Sun L; Xiang Y; Wang Z; Shi L J Mol Neurosci; 2012 Jun; 47(2):346-56. PubMed ID: 22528454 [TBL] [Abstract][Full Text] [Related]
14. Combination Therapy with AKT3 and PI3KCA siRNA Enhances the Antitumor Effect of Temozolomide and Carmustine in T98G Glioblastoma Multiforme Cells. Paul-Samojedny M; Pudełko A; Kowalczyk M; Fila-Daniłow A; Suchanek-Raif R; Borkowska P; Kowalski J BioDrugs; 2016 Apr; 30(2):129-44. PubMed ID: 26902608 [TBL] [Abstract][Full Text] [Related]
15. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2. Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849 [TBL] [Abstract][Full Text] [Related]
16. MALAT1 is a prognostic factor in glioblastoma multiforme and induces chemoresistance to temozolomide through suppressing miR-203 and promoting thymidylate synthase expression. Chen W; Xu XK; Li JL; Kong KK; Li H; Chen C; He J; Wang F; Li P; Ge XS; Li FC Oncotarget; 2017 Apr; 8(14):22783-22799. PubMed ID: 28187000 [TBL] [Abstract][Full Text] [Related]
17. Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities. Das A; Banik NL; Patel SJ; Ray SK Mol Cancer; 2004 Dec; 3(1):36. PubMed ID: 15588281 [TBL] [Abstract][Full Text] [Related]
18. Integrin αVβ3 silencing sensitizes malignant glioma cells to temozolomide by suppression of homologous recombination repair. Christmann M; Diesler K; Majhen D; Steigerwald C; Berte N; Freund H; Stojanović N; Kaina B; Osmak M; Ambriović-Ristov A; Tomicic MT Oncotarget; 2017 Apr; 8(17):27754-27771. PubMed ID: 27487141 [TBL] [Abstract][Full Text] [Related]
20. HDAC6 promotes cell proliferation and confers resistance to temozolomide in glioblastoma. Wang Z; Hu P; Tang F; Lian H; Chen X; Zhang Y; He X; Liu W; Xie C Cancer Lett; 2016 Aug; 379(1):134-42. PubMed ID: 27267806 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]